Coal tar
This article was originally published in The Tan Sheet
Executive Summary
Prop 65 lawsuit pending in California state court "has no direct relationship or bearing" on a citizen petition submitted by Occupational Knowledge International Executive Director Perry Gottesfeld requesting FDA review the safety of coal tar in treating dandruff, psoriasis and seborrheic dermatitis, California Attorney General Bill Lockyer asserts Aug. 23. Bergen Brunswig had submitted comments to FDA requesting a formal safety review of coal tar that would preempt the Prop 65 suit (1"The Tan Sheet" Sept. 4, p. 16). However, the AG says there is no cause for FDA intervention since "nothing in the state lawsuit will control the sale, use and distribution of the products"